Seek Returns

BNTX vs. ELAN: BioNTech vs. Elanco Animal Health Stock Comparison

How do BioNTech (BNTX) and Elanco Animal Health (ELAN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

BioNTech (BNTX) and Elanco Animal Health (ELAN) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but BNTX is classified in Biotechnology while ELAN is classified in Pharmaceuticals.

Elanco Animal Health (ELAN) trades as ordinary local shares, while BioNTech (BNTX) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile comparison for BioNTech (BNTX) and Elanco Animal Health (ELAN)
Profile ItemBNTXELAN
NameBioNTech SE American Depositary ShareElanco Animal Health Incorporated
Country/RegionGermanyUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnologyPharmaceuticals
GICS Sub-IndustryBiotechnologyPharmaceuticals
Market Capitalization21.70 billion USD12.86 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateOctober 10, 2019September 20, 2018
Security TypeADRCommon Stock

Price Performance

Cumulative Growth

BNTX
ELAN
GSPC
Loading price history…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for BioNTech (BNTX) and Elanco Animal Health (ELAN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for BioNTech (BNTX) and Elanco Animal Health (ELAN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for BioNTech (BNTX) and Elanco Animal Health (ELAN)
MetricBNTXELAN
Total Return (1Y)-14.78%24.03%
Total Return (3Y, Annualized)-3.99%37.47%
Total Return (5Y, Annualized)-17.02%-4.24%

Risk Profile

Drawdown History

BNTX
ELAN
GSPC
Loading price history…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for BioNTech (BNTX) and Elanco Animal Health (ELAN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for BioNTech (BNTX) and Elanco Animal Health (ELAN)
MetricBNTXELAN
Volatility (1Y, Annualized)47.44%43.57%
Beta (5Y)1.301.65
Max Drawdown (5Y)-78.10%-75.59%
Avg. Volume (3M)1.21M5.65M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
BNTX and ELAN are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for BioNTech (BNTX) and Elanco Animal Health (ELAN)
MetricBNTXELAN
Sharpe Ratio (1Y)-0.400.45
Sortino Ratio (1Y)-0.590.66

Profitability

ROE (TTM)

Elanco Animal Health (ELAN) has no ROE value reported for this period; BioNTech (BNTX) reports a negative figure of -8.14%, which needs context because negative ROE can reflect losses or negative shareholders’ equity.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

-8.14%

Max
109.18%
Q3
6.23%
BNTX
-8.14%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ELAN
--
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): ELAN does not report ROE, so it has no value marker; BNTX is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Both BioNTech (BNTX) at -60.87% and Elanco Animal Health (ELAN) at -2.86% report negative net margin values, usually indicating net losses over the period.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

-60.87%

Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
BNTX
-60.87%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-2.86%

Max
18.05%
Q3
4.78%
Median
0.00%
ELAN
-2.86%
Q1
-4.14%
Min
-17.05%
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

BioNTech (BNTX) at 30.28% operates in the top operating margin quartile, ahead of Elanco Animal Health (ELAN) at 6.64%, which runs around its industry’s norm.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

30.28%

Max
83.12%
BNTX
30.28%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.64%

Max
83.12%
Q3
14.77%
ELAN
6.64%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for BioNTech (BNTX) and Elanco Animal Health (ELAN)
MetricBNTXELAN
ROE (TTM)-8.14%--
ROA (TTM)-4.04%--
Net Margin (TTM)-60.87%-2.86%
Operating Margin (TTM)30.28%6.64%
Gross Margin (TTM)76.73%56.18%

Growth

Revenue Growth

Both BioNTech (BNTX) at 4.32% and Elanco Animal Health (ELAN) at 6.22% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Elanco Animal Health (ELAN) reports EPS growth of -169.12%, ranked against its industry; BioNTech (BNTX) has no EPS growth figure this period.

Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for BioNTech (BNTX) and Elanco Animal Health (ELAN)
MetricBNTXELAN
Revenue Growth (YoY)4.32%6.22%
Revenue Growth (3Y CAGR)-45.06%2.25%
EPS Growth (YoY)---169.12%
EPS Growth (3Y CAGR)----

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: BioNTech (BNTX) shows current ratio of 8.55 against its industry benchmark, while Elanco Animal Health (ELAN) has no reading this period.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.55

Max
25.13
Q3
12.13
BNTX
8.55
Median
5.52
Q1
2.47
Min
0.10

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
Min
0.10
ELAN
--
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): ELAN does not report current ratio, so it has no value marker; BNTX is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

BioNTech (BNTX) at 0.02 keeps leverage in the lower industry quartile, while Elanco Animal Health (ELAN) at 0.64 runs a more typical debt-to-equity mix.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.02

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
BNTX
0.02
Min
0.00

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.64

Max
1.42
Q3
0.65
ELAN
0.64
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for BioNTech (BNTX) and Elanco Animal Health (ELAN)
MetricBNTXELAN
Current Ratio (MRQ)8.55--
Debt / Equity (MRQ)0.020.64
Net Debt / EBITDA--3.49

Dividends

Dividend Yield (TTM)

Neither BioNTech (BNTX) nor Elanco Animal Health (ELAN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

BNTX
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Neither BioNTech (BNTX) nor Elanco Animal Health (ELAN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

BNTX
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for BioNTech (BNTX) and Elanco Animal Health (ELAN)
MetricBNTXELAN
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

Neither BioNTech (BNTX) nor Elanco Animal Health (ELAN) reports a P/E ratio value for this period, so a direct comparison isn’t possible.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
BNTX
--

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
ELAN
--
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): Neither stock reports P/E ratio, so the chart shows available benchmark boxes without value markers.

P/S Ratio (TTM)

Elanco Animal Health (ELAN) at 2.50 sits in the cheaper P/S ratio quartile while BioNTech (BNTX) at 8.96 prices around its industry’s middle — ELAN costs less per dollar of sales, though read it alongside growth and margins.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.96

Max
58.18
Q3
25.77
BNTX
8.96
Median
7.30
Q1
3.01
Min
0.01

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.50

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
ELAN
2.50
Min
0.01
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

BioNTech (BNTX) at 1.09 sits in the lower P/B ratio quartile against book while Elanco Animal Health (ELAN) at 1.95 is valued near its industry’s middle — BNTX is cheaper on assets, though weigh it against ROE and asset quality.

BNTX

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.09

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
BNTX
1.09
Min
-5.59

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.95

Max
13.53
Q3
6.54
Median
3.25
ELAN
1.95
Q1
1.69
Min
-5.59
Loading chart…
BioNTech (BNTX) vs. Elanco Animal Health (ELAN): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for BioNTech (BNTX) and Elanco Animal Health (ELAN)
MetricBNTXELAN
P/E Ratio (TTM)----
P/S Ratio (TTM)8.962.50
P/B Ratio (MRQ)1.091.95
Free Cash Flow Yield (TTM)-7.34%--